Profile | Manufacturers of Quality pharmaceutical Drugs Products in Africa and Latin America

News & Events

Bioequivalence study confirms that our artemether with lumefantrine combination is BIOEQUIVALENT to Coartem.

Malmed and Fantem range launched in Ghana

Malmed and Fantem range launched in Malawi.

Have launch OTC products under Ocean Health & Medical Pvt Ltd in a joint venture with foreign partners.

Completed stability studies for 14 days after reconstitution of FANTEM Suspension ( Artemether 180 with Lumefantrine 1080 ).

Registration of various our antimalarial products is in final stages of approval in FRANCOPHONE COUNTRIES.

Kenya Fantem tablets and Suspension is scheduled to be launched in the month of March 2009.

Fantem range launched in Zambia.

Infrastructure

Philosophy

Since, its inception MEDINOMICS driving force is to support the medical profession in promoting and preserving good health.

History

Madhushree Enterprises a global pharmaceutical marketing company, started its operation in 1996 and in a short span launched a subsidiary unit as MEDINOMICS with a manufacturing plant at Chennai & Indore in India. Since then Madhushree Enterprises has come a long way to reach a turnover of 8.0 Million USD.

Present

MEDINOMICS is focused to set standards in global markets. MEDINOMICS is confident to achieve a formidable position in pharmaceutical industry with its sound infrastructure and well qualified human force.

Future

MEDINOMICS believes in dynamism. It plans to constantly implement new ideas of marketing concepts by putting in restless efforts to pursue excellence. Its aim is to establish itself as an elegant company in global markets.